News Insulet has a challenger for Medtronic on the Horizon System proven effective in children and adolescents as well as adults.
News J&J diabetes drug hit by amputation risk Invokana produces modest CV benefit, but doubles risk of amputation
News Merck, Pfizer covering bases with SGLT2 inhibitor latecomer This year's American Diabetes Association conference takes place right next to San Diego's baseball stadium - and like the city's well-known Padres team, Merck and Pfizer are hoping to
News Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien... Companies awaiting CV outcomes trial, and court decision in patent case
News ADA to re-evaluate tweet ban after backlash ADA says photo ban is to protect intellectual property.
News Senate could back Trump health law by 4th July, despite warn... Reforms could take away health insurance from 23 million, and deny insurance to those with pre-existing conditions, such as diabetes
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
